Needle, injector, medication/vaccine

Access comprehensive regulatory information for Needle, injector, medication/vaccine in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Roche Diabetes Care Australia Pty Ltd, manufactured by HTL-Strefa S A in Poland. The device registration started on October 24, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.